Article Text

PDF
04 The regulation of mitochondrial energy metabolism by L-carnitine lowering agents in ischaemia-reperfusion injury
  1. M Makrecka1,2,
  2. J Kuka2,
  3. E Liepinsh2,
  4. M Dambrova1,2
  1. 1Riga Stradins University, Faculty of Pharmacy, Latvia
  2. 2Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Latvia

Abstract

Mitochondrial L-carnitine system plays an important role in energy metabolism of the cardiac cells. Administration of both mildronate and sodium pivalate decreases myocardial concentration of L- carnitine. However, mildronate induces cardioprotective effect, while administration of sodium pivalate results in ventricular dysfunction. The present study was performed to clarify the molecular mechanisms behind the opposite effects of both L-carnitine lowering agents. Mildronate (100 mg/kg) or sodium pivalate (500 mg/kg) were administered to Wistar rats for 14 days to reduce the L-carnitine content in heart tissues to comparable level. In heart tissues, L-carnitine content, activities of carnitine palmitoyltransferase I (CPT I) and carnitine acetyltransferase (CrAT) as well as mitochondrial respiration were measured. In addition, the isolated rat heart ischaemia-reperfusion experiments were performed to analyse the cardioprotective effects of both treatments. The L-carnitine content in heart tissues was decreased after treatment with pivalate (by 55%) and mildronate (by 69%). Pivalate and mildronate reduced CPT I activity by 43% and 19%, respectively. Both treatments decreased the mitochondrial respiration with palmitoyl-coenzyme A by 35% and 27%, respectively. Unlike mildronate, treatment with pivalate significantly decreased CrAT activity and respiration with pyruvate/malate by 28%. Only the treatment with mildronate induced significant reduction in infarct size by 34%. In conclusion, our results demonstrate that mildronate possess anti-infarction activity, but pivalate is devoid of cardioprotective effect due to detrimental effects on mitochondrial energy pathways. The regulation of L-carnitine availability can be used for cardioprotection, but the effects of pharmacological agents on mitochondrial L-carnitine pathways should be carefully monitored.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.